Fundamental and Clinical Studies on Aztreonam in Pediatrics

Keisuke Sunakawa, Nobuo Saito, Yugo Ishizuka, Satoshi Iwata, Yoshitake Sato, Hironobu Akita

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Fundamental and clinical results of AZT in pediatrics were as follows. 1. Pharmacokinetics of AZT was studied for 1 case with resulting high serum concentration and a halflife of approximate 1 hour. 2. AZT was administered to 10 patients with bacterial infections with 100% clinical efficacy and 62.5% bacterial elimination. Side effect was 1 case of diarrhea. 3. There were no abnormal laboratory or coagulation test findings nor vitamin K deficiency, platelet hypofunction or effects on intestinal bacterial flora. AZT was considered to be high in safety. 4. The administration of 20 mg/kg AZT 3 times a day was considered to be an effective treatment for pediatric Gram-negative infections.

Original languageEnglish
Pages (from-to)3230-3238
Number of pages9
Journalthe japanese journal of antibiotics
Issue number11
Publication statusPublished - 1985

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases


Dive into the research topics of 'Fundamental and Clinical Studies on Aztreonam in Pediatrics'. Together they form a unique fingerprint.

Cite this